![Kevin Colbert](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Kevin Colbert
Sociétés | Poste | Début | Fin |
---|---|---|---|
LifeSprout, Inc.
![]() LifeSprout, Inc. BiotechnologyHealth Technology LifeSprout, Inc. commercializes synthetic material made of hydrogel and polyester nanofibers. It aims to change the treatment of soft tissue losses with an injectable synthetic material that mimics living tissue. The company was founded by Russell Martin, Hai-Quan Mao, Justin Sacks, and Sashank Reddy in 2018 and is headquartered in Baltimore, MD. | Directeur des opérations | 01/01/2018 | - |
Fondateur | 01/01/2018 | - |
Historique de carrière de Kevin Colbert
Anciens postes connus de Kevin Colbert
Sociétés | Poste | Début | Fin |
---|---|---|---|
Glyscend, Inc.
![]() Glyscend, Inc. Pharmaceuticals: MajorHealth Technology Glyscend, Inc. engages in the development of therapeutics for treating metabolic diseases. It focuses on providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. The company was founded by Kevin Colbert in September 2014 and is headquartered in Baltimore, MD. | Fondateur | 01/09/2014 | - |
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Founder | 2 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
LifeSprout, Inc.
![]() LifeSprout, Inc. BiotechnologyHealth Technology LifeSprout, Inc. commercializes synthetic material made of hydrogel and polyester nanofibers. It aims to change the treatment of soft tissue losses with an injectable synthetic material that mimics living tissue. The company was founded by Russell Martin, Hai-Quan Mao, Justin Sacks, and Sashank Reddy in 2018 and is headquartered in Baltimore, MD. | Health Technology |
Glyscend, Inc.
![]() Glyscend, Inc. Pharmaceuticals: MajorHealth Technology Glyscend, Inc. engages in the development of therapeutics for treating metabolic diseases. It focuses on providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. The company was founded by Kevin Colbert in September 2014 and is headquartered in Baltimore, MD. | Health Technology |
- Bourse
- Insiders
- Kevin Colbert
- Expérience